DelveInsight’s Rheumatoid Arthritis (RA) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Rheumatoid Arthritis (RA) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Rheumatoid Arthritis (RA) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Rheumatoid Arthritis (RA) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Rheumatoid Arthritis (RA) market.
• Identifying patient populations in the global Rheumatoid Arthritis (RA) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Rheumatoid Arthritis (RA) therapeutics in each of the markets covered.
• To understand the future market competition in the global Rheumatoid Arthritis (RA) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Rheumatoid Arthritis (RA) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
Note: This report requires 7-10 business days to complete.
'
Table of Contents
• Rheumatoid Arthritis (RA) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Rheumatoid Arthritis (RA) Market
• Global Epidemiology of Rheumatoid Arthritis (RA) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Rheumatoid Arthritis (RA) Drug Sales (USD Millions)
• Table 6: Global Epidemiology of Rheumatoid Arthritis (RA) (2013-2023)
• Table 7: Rheumatoid Arthritis (RA) Global Market (USD Millions), (2013-2015)
• Table 8: Rheumatoid Arthritis (RA) Global Market (USD Millions), (2016-2023)
• Table 9: Rheumatoid Arthritis (RA) US Market (USD Millions), (2013-2015)
• Table 10: Rheumatoid Arthritis (RA) US Market (USD Millions), (2016-2023)
• Table 11: Rheumatoid Arthritis (RA) Germany Market (USD Millions), (2013-2015)
• Table 12: Rheumatoid Arthritis (RA) Germany Market (USD Millions), (2016-2023)
• Table 13: Rheumatoid Arthritis (RA) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Rheumatoid Arthritis (RA) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Rheumatoid Arthritis (RA) France Market (USD Millions), (2013-2015)
• Table 16: Rheumatoid Arthritis (RA) France Market (USD Millions), (2016-2023)
• Table 17: Rheumatoid Arthritis (RA) Italy Market (USD Millions), (2013-2015)
• Table 18: Rheumatoid Arthritis (RA) Italy Market (USD Millions), (2016-2023)
• Table 19: Rheumatoid Arthritis (RA) Spain Market (USD Millions), (2013-2015)
• Table 20: Rheumatoid Arthritis (RA) Spain Market (USD Millions), (2016-2023)
• Table 21: Rheumatoid Arthritis (RA) Japan Market (USD Millions), (2013-2015)
• Table 22: Rheumatoid Arthritis (RA) Japan Market (USD Millions), (2016-2023)
• Table 23: Rheumatoid Arthritis (RA) ROW Market (USD Millions), (2013-2015)
• Table 24: Rheumatoid Arthritis (RA) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Rheumatoid Arthritis (RA) Drug Sales (USD Millions)
• Figure 2: Global Epidemiology of Rheumatoid Arthritis (RA) (2013-2023)
• Figure 3: Rheumatoid Arthritis (RA) Global Market (USD Millions), (2013-2015)
• Figure 4: Rheumatoid Arthritis (RA) Global Market (USD Millions), (2016-2023)
• Figure 5: Rheumatoid Arthritis (RA) US Market (USD Millions), (2013-2015)
• Figure 6: Rheumatoid Arthritis (RA) US Market (USD Millions), (2016-2023)
• Figure 7: Rheumatoid Arthritis (RA) Germany Market (USD Millions), (2013-2015)
• Figure 8: Rheumatoid Arthritis (RA) Germany Market (USD Millions), (2016-2023)
• Figure 9: Rheumatoid Arthritis (RA) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Rheumatoid Arthritis (RA) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Rheumatoid Arthritis (RA) France Market (USD Millions), (2013-2015)
• Figure 12: Rheumatoid Arthritis (RA) France Market (USD Millions), (2016-2023)
• Figure 13: Rheumatoid Arthritis (RA) Italy Market (USD Millions), (2013-2015)
• Figure 14: Rheumatoid Arthritis (RA) Italy Market (USD Millions), (2016-2023)
• Figure 15: Rheumatoid Arthritis (RA) Spain Market (USD Millions), (2013-2015)
• Figure 16: Rheumatoid Arthritis (RA) Spain Market (USD Millions), (2016-2023)
• Figure 17: Rheumatoid Arthritis (RA) Japan Market (USD Millions), (2013-2015)
• Figure 18: Rheumatoid Arthritis (RA) Japan Market (USD Millions), (2015-2023)
• Figure 19: Rheumatoid Arthritis (RA) ROW Market (USD Millions), (2013-2015)
• Figure 20: Rheumatoid Arthritis (RA) ROW Market (USD Millions), (2016-2023)
• Mitsubishi Tanabe Pharma Corporation
• TheraMAB
• Can-Fite BioPharma
• Incyte Corporation
• Novo Nordisk
• Pfizer
